By Shawn Elliott, CFO | High Rock Accounting
Not too long ago I sat down with a founder to walk through his balance sheet for the first time. Delaware C Corp, four founders, smart team, building a real product, and they had been operating with the kind of focus you see in companies that are going to make it. The cap table looked clean enough at first glance. Tax return tied. Cash reconciled. And then we got to the equity section, and I saw $75,000 sitting in something called “owner contributions” from year one, with another chunk of SAFEs from the prior year hanging out in a similar plug account.
That is not where SAFE notes go. And the founder, who had done a really nice job setting the company up on Carta from day one with all the right share classes and option pool ratios, had no idea, because nobody had told him.
Here is the part that matters. When that founder eventually heads into Series A diligence, the lead investor is going to send a financial diligence checklist that includes a full review of the equity section, every convertible instrument outstanding, and tie-out to the cap table. If a $400,000 SAFE round is sitting in additional paid-in capital instead of in a liability where GAAP says it usually belongs, that is the kind of thing that does not just generate a question. It generates concern. It tells the investor that the books were not built by someone who knew what they were doing, and now they are wondering what else is wrong in there.
SAFE notes have completely taken over the early-stage market. The Y Combinator instrument that did not exist until late 2013 now accounts for the overwhelming majority of pre-seed and seed deals. Carta data shows that 92% of pre-seed rounds in Q3 of 2025 used SAFEs.
That means an enormous number of founders are sitting on cash from SAFE rounds right now, and a meaningful percentage of them have the journal entry wrong. Let me walk through what that journal entry actually should look like, why most founders get it wrong, and how to clean it up before a priced round forces the issue.
Why a SAFE Is Usually a Liability, Not Equity
The instinctive thing to do when cash comes in from investors is to credit equity, because that is what investor cash usually does. SAFE stands for Simple Agreement for Future Equity, which has the word equity right there in the name, and the whole purpose of the instrument is to convert into stock down the road when you do your priced round. So founders look at all of that and think, “this is equity, let me drop it into APIC.”
And under GAAP, that is almost always wrong.
The technical framework lives in ASC 480, which is the standard for distinguishing liabilities from equity, and you have to walk through it in a specific order. The starting point is whether the SAFE embodies an obligation that requires settling with a variable number of shares based predominantly on a fixed monetary amount known at inception. Most SAFEs do exactly that. You took in $500,000, the conversion math at the priced round will produce whatever number of shares is required to deliver the agreed ownership percentage, and that number of shares is variable because it depends on the priced-round share price. Under ASC 480, that kind of obligation is required to be classified as a liability.
If for some reason a SAFE does not get caught by ASC 480, the next step is to evaluate it under ASC 815-40, which deals with derivatives and contracts in an entity’s own equity. Most SAFEs do not pass that test either, which means they fall back into liability classification.
Practitioners in this space have been pretty consistent on where this ends up. The Private Company Council, which advises FASB, has acknowledged that there is some diversity in practice, but the prevailing view among technical accounting professionals is that most SAFEs end up as liabilities and not as equity.
So the practical rule of thumb, until your auditor or a technical accounting specialist tells you otherwise in writing for your specific SAFE, is that the credit goes to a liability account. Not APIC. Not common stock. A separate balance sheet line called something like “SAFE notes” or “Convertible instruments at fair value,” and it sits in the liability section until conversion.
What the Journal Entry Actually Looks Like
The mechanics are pretty straightforward once you accept that SAFEs are a liability. When the cash hits the bank, you book a debit to cash for the proceeds and a credit to a SAFE liability account for the same amount, because the initial measurement is the fair value at issuance, and the fair value at issuance is generally the cash you received. So a $500,000 SAFE comes in at $500,000.
Then comes the part that trips people up. Because the SAFE is a liability that gets measured at fair value going forward, you are technically required to remeasure it at each reporting period and run the change through the P&L. If the company’s valuation goes up between the time you took in the SAFE and the next balance sheet date, the fair value of the SAFE liability goes up too, and that increase shows up as a non-cash expense.
Now, in practice, the remeasurement is a judgment call that most early-stage companies handle a couple of different ways. Some companies hold the SAFE at issuance value until conversion or until something material changes, with proper disclosure. Some companies do a more formal fair value mark at year end. The right answer depends on materiality, on what your future auditor will accept, and on whether you are doing a GAAP audit or just preparing tax-basis financials. If you are pre-revenue and pre-audit, the issuance value approach is usually defensible. Once you are heading into audit territory, you want a technical accountant or your auditor weighing in on the fair value methodology before you finalize the books.
When the SAFE finally converts at the priced round, the entry is a debit to the SAFE liability for whatever balance is sitting there, and a credit to common stock, preferred stock, and APIC based on the conversion math from the cap table.
So if you took in $500,000 on a $10 million post-money valuation cap, and your Series A prices at $20 million pre-money, the SAFE converts at the cap because the cap is more favorable, and the resulting equity issuance hits common or preferred stock at par value with the rest going to APIC. The SAFE liability comes off the balance sheet entirely.
Your Cap Table System Has to Be the Source of Truth
Here is the thing that catches founders. You can have the right journal entries in Xero, but if the underlying SAFE documents are not properly recorded in your cap table system, like Carta or Pulley or one of the other modern platforms, the diligence team will not be able to follow the breadcrumbs from the cash you took in to the eventual ownership those investors are owed. And that is going to slow your raise down considerably.
I have had this exact scenario play out with a client. Money came in across multiple SAFE tranches over a period of months, all from the same investor class, and the company had not yet gotten the source documents loaded into Carta. So when we did the monthly close and saw the cash hitting the bank, we coded it to convertible instruments based on the descriptions we had, but without the actual signed SAFEs and the conversion terms in Carta, we did not have what we needed to roll forward to the eventual equity issuance. That is fine for a month or two of cleanup work, but it cannot be the long-term state of your books.
The pattern you want is this. Every SAFE gets signed, gets a fully executed PDF, gets uploaded into Carta with the cap, the discount if any, the post-money or pre-money designation, the conversion triggers, and any side letter terms. Then when the cash hits Brex or Ramp or wherever your operating account lives, your accountant books it to the SAFE liability account in Xero, references the Carta SAFE ID in the journal entry detail, and you have a clean tie from bank to GL to cap table. When diligence asks for it, you hand it over on a silver platter.
Five Mistakes I See Founders Making on SAFE Accounting
In my experience, the misclassification problem is rarely just one thing. It tends to be a cluster of small errors that compound, and the cleanup is more painful the longer you wait. Here are the patterns I see most often.
1. Crediting APIC at issuance
This is the big one, and it is the one that will get flagged the fastest. The cash comes in, the founder or their bookkeeper sees an investor name on the wire, and they assume it is equity. APIC goes up by $500,000, and now your equity section looks like you raised a priced round when in fact you have a contingent obligation sitting there. The fix is to reclassify by reversing the APIC entry and crediting a SAFE liability account in its place, with documentation tying back to the source SAFE.
2. Parking the proceeds in “owner contributions” or some plug account
I see this with founders who set up the books before they had a real accountant. The cash came in, they did not know what to do with it, and it landed in something generic. Owner contributions makes some intuitive sense because the founders are the owners and the money showed up, but if your SAFEs are from outside investors, they are not owner contributions, they are convertible instruments owed to third parties.
3. Not recording the SAFE in Carta
Even when the GL is right, the cap table system has to mirror it. If your accountant has SAFEs on the balance sheet that do not appear in Carta, that is a sanity-check failure during diligence. The cap table is the source of truth for the legal ownership story, and the GL is the source of truth for the accounting story. The two have to reconcile.
4. Mixing SAFE terms without tracking them separately
Most pre-seed founders raise from somewhere between five and 15 investors using multiple SAFEs with slightly different terms.
Different valuation caps, some with discounts and some without, some MFN clauses, sometimes a side letter. If you are treating them all as one undifferentiated bucket on your balance sheet and in your cap table, the conversion math at Series A is going to be a mess, and the diligence team will spot it immediately.
5. Ignoring the fair value question entirely
If the SAFE is a liability that is supposed to be remeasured at fair value, and you have just been holding it at face value for two years without any reassessment or even a disclosure, that is something a technical accountant or auditor is going to want to discuss. It is not necessarily wrong for an early-stage pre-audit company, but you need to be deliberate about it and document the reasoning, not just ignore the question.
The Game Plan Before Your Priced Round
If you are reading this and you suspect your SAFE notes are not where they should be on the balance sheet, here is what to do in the order I would do it.
First, pull every signed SAFE you have and lay them out in a single folder. Get the principal amount, the date of issuance, the valuation cap, any discount, whether it is post-money or pre-money, and any side letter terms documented in one place. The post-money SAFE with a valuation cap and no discount is now the dominant structure in the market, but you may have a mix of older pre-money SAFEs in there from earlier rounds.
Second, make sure every one of those SAFEs is properly entered in Carta or whichever cap table system you use, with all of the relevant terms keyed in. If anything is missing, get with your attorney and get it uploaded.
Third, reconcile your GL to the cap table. The total of your SAFE liability account in Xero should equal the total of all outstanding SAFE proceeds in Carta. If those two numbers do not tie, you have a problem to chase down before any investor sees the books.
Fourth, if your SAFEs are currently sitting in APIC or owner contributions or any equity account, do the reclassification entries to move them to a liability. Have a memo on file explaining the reclassification rationale, with reference to ASC 480, so that when your auditor or the diligence team asks, you have a clean answer.
Fifth, talk to your accountant or fractional CFO about the fair value question. Most early-stage companies can defend an issuance-value approach with proper disclosure, but you want that decision documented before audit, not improvised after.
In that type of scenario, you go into Series A diligence with books that match the cap table, a clean liability presentation that follows the prevailing technical accounting view, and a story that tells the investor you have been running the business with adult supervision from day one. That is exactly what they want to see, and it makes the diligence process go faster, not slower.
If you are a pre-seed or seed founder and you are not sure where your SAFEs are sitting today, this is the kind of thing we sort out all the time. We are just a Slack message away if you want a sanity check before the diligence requests start landing in your inbox.
Two Easy Ways to Get a Second Set of Eyes on This
Hawaiian Shirt Friday: Ask an Accountant Hour meets every Friday at 10AM Pacific Time, open Zoom, no appointment needed. Bring your balance sheet questions, your SAFE conversion math, or anything else you are wrestling with. Join here: https://us02web.zoom.us/j/88992505122?pwd=LdbL4NYxN2NNk5RanaHRVtrHgT43O9.1
Prefer a one-on-one conversation? Grab a 30-minute slot on my calendar to walk through your specific situation: https://meetings-na2.hubspot.com/shawn-elliott/30-minute-meeting
Sources
1. Carta, “State of Pre-Seed: Q3 2025” / FutureSight Ventures benchmarks summary (Jan 2026): SAFEs were used in 92% of pre-seed rounds as of Q3 2025. carta.com/data/state-of-pre-seed-q3-2025 and futuresight.ventures benchmarks recap.
2. Grant Thornton, “Issuers’ accounting for SAFEs” Viewpoint (2024): walks through ASC 480 and ASC 815-40 analysis for issuer classification of SAFE instruments. grantthornton.com viewpoint publication.
3. PwC Viewpoint, “5.5 Application of ASC 480” (June 2024): ASC 480 applies to freestanding equity and equity-linked financial instruments and requires liability classification under specific conditions. viewpoint.pwc.com.
4. Thomson Reuters Tax & Accounting, “Accounting Rules for a Simple Agreement for Future Equity Raising Concerns, FASB Private Company Panel Says” (Sept 2023): coverage of PCC discussion on diversity in practice and the prevailing view that most SAFEs end up classified as liabilities. tax.thomsonreuters.com.
5. Shay CPA, “SAFE Notes: Accounting, Tax Rules, and QSBS Issues Startup Founders Need to Know” (2026): explains initial cash journal entry to SAFE liability account and conversion mechanics at priced round. shaycpa.com.
6. Crunchbase News, “Startups Venture” coverage of Carta SAFE data (2024): notes that pre-seed founders typically raise from five to 15 investors using multiple SAFEs with varying terms, and median dilution from large SAFE rounds hovers around 20%. news.crunchbase.com.
7. Y Combinator, “YC Safe Financing Documents” (current): documents the evolution from pre-money to post-money SAFE structures and the current standard forms. ycombinator.com/documents. Also: Velawood, “Post-Money Safe Does Not Mean Founders Equity is Safe” (Aug 2025), citing Carta data that post-money SAFEs accounted for 83% of all SAFEs issued in 2024. velawood.com.
Enjoyed this article? Consider Sharing
Author
